e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Airway disease-associated exacerbations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inappropriate Utilization of Antibiotics in COPD Exacerbations
Y. Varol (Izmir, Turkey), Z. Karakurt (Istanbul, Turkey), A. Cirak (Izmir, Turkey), H. Sahin (Izmir, Turkey), C. Kirakli (Izmir, Turkey), B. Komurcuoglu (Izmir, Turkey)
Source:
International Congress 2019 – Airway disease-associated exacerbations
Session:
Airway disease-associated exacerbations
Session type:
Thematic Poster
Number:
4283
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Varol (Izmir, Turkey), Z. Karakurt (Istanbul, Turkey), A. Cirak (Izmir, Turkey), H. Sahin (Izmir, Turkey), C. Kirakli (Izmir, Turkey), B. Komurcuoglu (Izmir, Turkey). Inappropriate Utilization of Antibiotics in COPD Exacerbations. 4283
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Audit of Duration of Corticosteroid Treatment in Acute Exacerbations of COPD
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018
Mechanisms of Acute Exacerbations in COPD
Source: ERS Lung Science Conference 2019
Year: 2019
Causes and management of exacerbations of COPD
Source: ISSN=ISSN 1810-6838, ISBN=, page=250
Year: 2007
Exacerbations of COPD
Source: Eur Respir Rev, 27 (147) 170103; 10.1183/16000617.0103-2017
Year: 2018
Microbiome Use to Stratify Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (MUSIC) trial: baseline data and impact of inhaled corticosteroid withdrawal in severe COPD with frequent exacerbations
Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils
Year: 2020
30-day Readmissions After Acute Exacerbations of COPD: How Relevant Are Comorbidities?
Source: Virtual Congress 2020 – Diagnosis and management of COPD
Year: 2020
Blood Eosinophils and Outcomes in Severe Hospitalized Exacerbations of COPD.
Source: International Congress 2017 – COPD biomarkers
Year: 2017
Antibiotics in exacerbations of asthma
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
Exacerbations of Asthma
Source: Eur Respir J 2007; 29: 1071
Year: 2007
Effectiveness of Mepolizumab in Reducing Asthma Exacerbations in Japan
Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Year: 2020
Targeted Retreatment of Incompletely Resolved COPD Exacerbations With Ciprofloxacin
Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Year: 2019
Predictors of exacerbations in patients with bronchiectasis
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
Exacerbations of COPD and treatment
Source: International Congress 2018 – PG1 Asthma and chronic obstructive pulmonary disease
Year: 2018
Frequency of COPD exacerbations in the real-life out-patient DACCORD cohort
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014
Role of comorbidities on mortality in patients hospitalized for COPD exacerbations
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Recommendations on long-term antibiotics and mucolytics for prevention of exacerbations of COPD
Source: International Congress 2017 – Treatment and prevention of COPD exacerbation
Year: 2017
Predictors of exacerbations in asthma
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
Management of COPD exacerbations
Source: ERS Lung Science Conference 2019
Year: 2019
Role of Comorbidities and BMI on the Efficacy of Non Invasive Ventilation in COPD with Chronic Hypercapnia.
Source: International Congress 2018 – Non-invasive ventilation in chronic respiratory failure
Year: 2018
Impact of halotherapy on COPD exacerbations
Source: International Congress 2019 – COPD treatment: cohorts and real-world studies
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept